ProQR Therapeutics NV (NASDAQ:PRQR)

1.48
Delayed Data
As of 3:58pm ET
 +0.055 / +3.87%
Today’s Change
0.53
Today|||52-Week Range
8.60
-81.59%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 1.32, with a high estimate of 2.11 and a low estimate of 0.84. The median estimate represents a -10.79% decrease from the last price of 1.48.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in ProQR Therapeutics NV. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.19
Sales
$959.5K
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 44.38%
 
 
 
 
 
 
Growthannually 0.99%
 
 
 
 
 
 

Sales

Growthquarterly 0.37%
 
 
 
 
 
 
Growthannually 200.32%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.